4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Incannex Healthcare Inc. (IXHL) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Melbourne, Australia with about 12 employees. Its market capitalization is roughly $34 million. In the fiscal year ended 2026-06-30, IXHL reported $0M in revenue and ($19M) in net income.
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.
Interactive charts & full statements →
| Income statement | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Revenue | $0M | — | $0M | $0M | $0M |
| Gross Profit | — | — | — | $0M | $0M |
| Operating Income (EBIT) | ($23M) | — | ($30M) | ($50M) | ($10M) |
| Net Income | ($19M) | — | ($18M) | ($49M) | ($10M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — | $0M |
| Operating Income (EBIT) | ($5M) | ($4M) | ($7M) | ($7M) | — | ($5M) |
| Net Income | ($2M) | ($4M) | ($6M) | ($6M) | — | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Assets | $73M | — | $17M | $24M | $26M |
| Total Liabilities | $6M | — | $6M | $3M | $1M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IXHL viewer.
About TickerBase · Data methodology & sources · Privacy · Terms